首页> 外国专利> CELLULAR RECEPTORS UTILIZED AS CARRIER AGENTS FOR PHARMACEUTICAL COMPOUNDS USED IN TUMOR IMAGING AND CANCER TREATMENT

CELLULAR RECEPTORS UTILIZED AS CARRIER AGENTS FOR PHARMACEUTICAL COMPOUNDS USED IN TUMOR IMAGING AND CANCER TREATMENT

机译:细胞受体用作肿瘤成像和癌症治疗中的药物化合物的载体

摘要

A method whereby non-immunogenic intraspecies proteins are used as carrier compounds to deliver imaging agents and pharmaceutical drugs to tumors in the human patient. This invention describes the propensity of certain solubilized cellular receptor proteins to localize in necrotic or inflamed areas of tumors but not in healthy normal tissues. Two examples of these receptors are tumor necrosis factor receptor (TNF-R) and the interleukin receptors (IL-R). By combining various pharmaceutical agents with these receptor proteins it is possible to localize these agents within the necrotic or damaged areas of the tumor where they will have the greatest therapeutic effect.
机译:一种将非免疫原性种内蛋白用作载体化合物以将显像剂和药物递送至人类患者肿瘤的方法。本发明描述了某些增溶的细胞受体蛋白倾向于定位在肿瘤的坏死或发炎区域,而不是健康的正常组织。这些受体的两个例子是肿瘤坏死因子受体(TNF-R)和白介素受体(IL-R)。通过将各种药剂与这些受体蛋白结合,可以将这些药剂定位在肿瘤的坏死或受损区域内,在该区域它们将具有最大的治疗效果。

著录项

  • 公开/公告号EP1768707A2

    专利类型

  • 公开/公告日2007-04-04

    原文格式PDF

  • 申请/专利权人 SMITH JAMES R.;SMITH HENRY J.;

    申请/专利号EP20050806724

  • 发明设计人 SMITH JAMES R.;SMITH HENRY J.;

    申请日2005-07-22

  • 分类号A61K51;A61K49/04;

  • 国家 EP

  • 入库时间 2022-08-21 20:44:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号